01/About

VectorPoint helps emerging and growth-stage biopharma companies navigate the path to successful commercialization.

We provide strategic marketing, launch planning, commercial operations, and interim executive leadership across rare disease, oncology, hematology, and cell & gene therapy — accelerating commercialization through experienced leadership, practical execution, and strategic partnership.

  • 20+Years leading commercialization
  • 10+Launches and Indications
02/Journey

One continuous line of commercial thinking across all stages

Commercialization is a sequence, not an event. We plug into the stage you are in — and stay through the ones that follow.

Stage 01Typical window: T−24 to T−3

Commercial Readiness

Preparing an organization for launch requires cross-functional planning, governance, market preparation, and operational excellence.

VectorPoint provides experienced leadership to ensure organizations are prepared for successful commercialization.

What VectorPoint delivers
  • D.01Launch readiness assessment and planning
  • D.02Governance and decision architecture
  • D.03Cross-functional launch planning
  • D.04Market preparation and operational build
Stage 02Typical window: T−6 to T+6

Product Launch

Successful launches require strategic execution, alignment across functions, and the ability to adapt quickly.

VectorPoint supports launch planning, execution, commercial operations, and interim leadership during critical launch periods.

What VectorPoint delivers
  • D.05Launch execution and tactical delivery
  • D.06Cross-functional alignment and cadence
  • D.07Commercial operations and launch analytics
  • D.08Interim commercial leadership
Stage 03Typical window: T+6 and beyond

Market Growth

Commercialization does not end at launch.

VectorPoint helps organizations optimize commercial performance, evolve brand strategy, improve operational effectiveness, and prepare for future indications or portfolio expansion.

What VectorPoint delivers
  • D.09Commercial performance optimization
  • D.10Brand strategy evolution
  • D.11Operational effectiveness improvement
  • D.12Future indication and portfolio expansion
Engagement RailMonths relative to launch
03/Leadership

A commercial executive with more than 20 years leading commercialization strategy.

Portrait of Joshua Rodriguez, Founder & Principal Consultant of VectorPoint Commercial Advisors, LLC

Joshua RodriguezFounder & Principal Consultant

Across oncology, hematology, rare disease, and cell & gene therapy — with more than ten product launches and indications supported across multiple therapeutic areas.